BACKGROUND: In candidate patients for permanent hemodialysis or dialysis on a regular basis, an appropriate vascular access has great importance.
The best permanent access is AVF (arterio venous fistula). Use of a technique to create AVF with better patency seems to be logical.
OBJECTIVES: The present study aimed to compare the efficacy rate of AVFs using two different anastomosis methods; Side to Side (STS) versus End to Side (ETS) and to determine whether the different approaches render any preferences or complications.
PATIENTS AND METHODS: Sixty end stage renal disease (ESRD) patients were included in this clinical trial in two assigned groups of 30 patients. In one group end to side method to create AVF was used while in the other group Side to Side technique was applied for access in surgery. Both groups were followed for duration of 6 months to assess patency. For evaluating the quantitive variables, t-test was used while qualitative variables were measured using the chi-square and Fisher`s exact tests.
RESULTS: In the 6 months duration, 6 patients (20%) in the STS (side to side) group and 5 patients (16.6%) in the ETS (end to side) group experienced a non-functional AVF. In the ETS group the failure was generally a result of thrombosed access while in the STS group, 4 out of 6 patients with complications, experienced thrombosis while the other 2 patients had venous hypertension. The total failure rate was 18.3% and during the 6 months of follow up no significant difference was detected in the efficacy rate. Nevertheless, in case of longer follow ups, different outcomes could be seen.
CONCLUSIONS: This study demonstrated that there was no significant statistical difference between the functional patency rates of fistulae placed by STS or ETS methods.
Written by:
Mozaffar M, Fallah M, Lotfollahzadeh S, Sobhiyeh MR, Gholizadeh B, Jabbehdari S, Mahdi Z. Are you the author?
General and Vascular Surgery Division, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, IR Iran.
Reference: Nephrourol Mon. 2013 Jul 1;5(3):827-830.
doi: 10.5812/numonthly.10248
PubMed Abstract
PMID: 24282794
UroToday.com Renal & Vascular Diseases Section
